RecruitingNCT06805409

VExUS in Ards Patients and Association with AKI

Evaluation of Venous Congestion Using Doppler and Venous Excess Ultrasound Score (VExUS) During Acute Respiratory Distress Syndrome and Its Association with Acute Kidney Injury

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

120 participants

Start Date

Dec 2, 2024

Study Type

OBSERVATIONAL

Conditions

Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

Summary

A single-center prospective observational study will be conducted with the aim of determining the prevalence of venous congestion during ARDS using venous Doppler and the VExUS score.

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with acute lung injury/acute respiratory distress syndrome (ards). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 100 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Armand MEKONTSO DESSAP

Créteil, Val de Marne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06805409

Related Trials